Verona Pharma plc, of London, completed a placing, conditional on admission and in part on shareholder approval, to raise gross proceeds of approximately £3.25 million (US$5.08 million). The placing, which was arranged by WH Ireland Ltd., involved the issue of up to 65,020,120 new ordinary shares at 5 pence per share.